Tecan will manufacture Enigma's new point-of-care molecular diagnostic instrument under a five-year deal.
Chris Wagner, Brad Popovich, Jorge Garces, Greg Hamilton, Nick Williams, Darren Hall
The British molecular diagnostics firm also announced executive appointments for both the US and European operations.
The firms will develop tests to run on Enigma's ML platform. As part of the alliance, GSK will make an equity investment in the molecular diagnostics startup.
Enigma Diagnostics gained access to two Roche patents for use in its multiplex PCR tests for human and animal diseases.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
The World Health Organization has announced the members of its gene-editing committee, according to NPR.
DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.
The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.
In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.